Your browser doesn't support javascript.
loading
Neoantigen-directed immune escape in lung cancer evolution.
Rosenthal, Rachel; Cadieux, Elizabeth Larose; Salgado, Roberto; Bakir, Maise Al; Moore, David A; Hiley, Crispin T; Lund, Tom; Tanic, Miljana; Reading, James L; Joshi, Kroopa; Henry, Jake Y; Ghorani, Ehsan; Wilson, Gareth A; Birkbak, Nicolai J; Jamal-Hanjani, Mariam; Veeriah, Selvaraju; Szallasi, Zoltan; Loi, Sherene; Hellmann, Matthew D; Feber, Andrew; Chain, Benny; Herrero, Javier; Quezada, Sergio A; Demeulemeester, Jonas; Van Loo, Peter; Beck, Stephan; McGranahan, Nicholas; Swanton, Charles.
Afiliación
  • Rosenthal R; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, London, UK.
  • Cadieux EL; Bill Lyons Informatics Centre, University College London Cancer Institute, University College London, London, UK.
  • Salgado R; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Bakir MA; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK.
  • Moore DA; Department of Pathology, GZA-ZNA, Antwerp, Belgium.
  • Hiley CT; Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia.
  • Lund T; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Tanic M; Department of Pathology, University College London Cancer Institute, University College London, London, UK.
  • Reading JL; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, London, UK.
  • Joshi K; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Henry JY; Cancer Immunology Unit, University College London Cancer Institute, University College London, London, UK.
  • Ghorani E; Research Department of Haematology, University College London Cancer Institute, University College London, London, UK.
  • Wilson GA; Department of Cancer Biology, University College London Cancer Institute, University College London, London, UK.
  • Birkbak NJ; Cancer Immunology Unit, University College London Cancer Institute, University College London, London, UK.
  • Jamal-Hanjani M; Research Department of Haematology, University College London Cancer Institute, University College London, London, UK.
  • Veeriah S; Cancer Immunology Unit, University College London Cancer Institute, University College London, London, UK.
  • Szallasi Z; Research Department of Haematology, University College London Cancer Institute, University College London, London, UK.
  • Loi S; Cancer Immunology Unit, University College London Cancer Institute, University College London, London, UK.
  • Hellmann MD; Research Department of Haematology, University College London Cancer Institute, University College London, London, UK.
  • Feber A; Cancer Immunology Unit, University College London Cancer Institute, University College London, London, UK.
  • Chain B; Research Department of Haematology, University College London Cancer Institute, University College London, London, UK.
  • Herrero J; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, London, UK.
  • Quezada SA; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Demeulemeester J; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, London, UK.
  • Van Loo P; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Beck S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, London, UK.
  • McGranahan N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, London, UK.
  • Swanton C; Computational Health Informatics Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Nature ; 567(7749): 479-485, 2019 03.
Article en En | MEDLINE | ID: mdl-30894752
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Escape del Tumor / Evolución Molecular / Neoplasias Pulmonares / Antígenos de Neoplasias Tipo de estudio: Prognostic_studies Límite: Female / Humans / Male Idioma: En Revista: Nature Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Escape del Tumor / Evolución Molecular / Neoplasias Pulmonares / Antígenos de Neoplasias Tipo de estudio: Prognostic_studies Límite: Female / Humans / Male Idioma: En Revista: Nature Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido